All Relations between Anxiety Disorders and cannabis

Publication Sentence Publish Date Extraction Date Species
Keya Mallick, Mohd Faiz Khan, Sugato Banerje. The anxiolytic effects of cannabinoids: A comprehensive review. Pharmacology, biochemistry, and behavior. vol 243. 2024-07-21. PMID:39032530. cannabinoids, notably cannabidiol (cbd) and delta-9-tetrahydrocannabinol (thc), have emerged as promising candidates for anxiety disorder treatment, supported by both preclinical and clinical evidence. 2024-07-21 2024-07-24 Not clear
João Luís Queiroz Simei, José Diogo Ribeiro de Souza, João Roberto Lisboa, Francisco Silveira Guimarães, José Alexandre de Souza Cripp. Cannabidiol in anxiety disorders: Current and future perspectives. International review of neurobiology. vol 177. 2024-07-19. PMID:39029985. cannabidiol in anxiety disorders: current and future perspectives. 2024-07-19 2024-07-22 Not clear
João Luís Queiroz Simei, José Diogo Ribeiro de Souza, João Roberto Lisboa, Francisco Silveira Guimarães, José Alexandre de Souza Cripp. Cannabidiol in anxiety disorders: Current and future perspectives. International review of neurobiology. vol 177. 2024-07-19. PMID:39029985. since the 1970s, basic and clinical research on cannabidiol (cbd), a non-psychotomimetic compound found in the cannabis sativa plant, has indicated relevant anxiolytic effects, garnering attention for its therapeutic potential as an option in anxiety disorder treatment. 2024-07-19 2024-07-22 Not clear
Stephen D S McCarthy, Jennifer Xiao, Michael Pugliese, Laurent Perrault-Sequeira, Daniel T Myra. Changes in cannabis involvement in emergency department visits for anxiety disorders after cannabis legalization: a repeated cross-sectional study. Lancet regional health. Americas. vol 36. 2024-07-08. PMID:38974381. one concern is that legalization of cannabis will result in increased cannabis use and in turn a higher prevalence of anxiety disorders. 2024-07-08 2024-07-11 Not clear
Stephen D S McCarthy, Jennifer Xiao, Michael Pugliese, Laurent Perrault-Sequeira, Daniel T Myra. Changes in cannabis involvement in emergency department visits for anxiety disorders after cannabis legalization: a repeated cross-sectional study. Lancet regional health. Americas. vol 36. 2024-07-08. PMID:38974381. changes in cannabis involvement in emergency department visits for anxiety disorders after cannabis legalization: a repeated cross-sectional study. 2024-07-08 2024-07-11 Not clear
Stephen D S McCarthy, Jennifer Xiao, Michael Pugliese, Laurent Perrault-Sequeira, Daniel T Myra. Changes in cannabis involvement in emergency department visits for anxiety disorders after cannabis legalization: a repeated cross-sectional study. Lancet regional health. Americas. vol 36. 2024-07-08. PMID:38974381. we examined changes in emergency department (ed) visits for anxiety disorders with cannabis involvement in ontario, over a period that involved medical and non-medical cannabis legalization. 2024-07-08 2024-07-11 Not clear
Rebecca K Denson, Julia Brooks, Graziano Pinna, Natania A Cran. Effects of Cannabidiol in Adolescent and Young Adult Depressive and Anxiety Disorders: A Systematic Review of Clinical and Preclinical Research. Adolescent psychiatry (Hilversum, Netherlands). vol 13. issue 3. 2024-06-26. PMID:38919887. effects of cannabidiol in adolescent and young adult depressive and anxiety disorders: a systematic review of clinical and preclinical research. 2024-06-26 2024-06-29 Not clear
Kevin Han, Jia-Yu Wang, Peng-Yun Wang, Yue-Chu-Han Pen. Therapeutic potential of cannabidiol (CBD) in anxiety disorders: A systematic review and meta-analysis. Psychiatry research. vol 339. 2024-06-26. PMID:38924898. therapeutic potential of cannabidiol (cbd) in anxiety disorders: a systematic review and meta-analysis. 2024-06-26 2024-06-29 human
Daniel T Myran, Lyndsay D Harrison, Michael Pugliese, Peter Tanuseputro, Adrienne Gaudreault, Jess G Fiedorowicz, Marco Solm. Development of an anxiety disorder following an emergency department visit due to cannabis use: a population-based cohort study. EClinicalMedicine. vol 69. 2024-03-28. PMID:38544799. development of an anxiety disorder following an emergency department visit due to cannabis use: a population-based cohort study. 2024-03-28 2024-03-30 Not clear
Daniel T Myran, Lyndsay D Harrison, Michael Pugliese, Peter Tanuseputro, Adrienne Gaudreault, Jess G Fiedorowicz, Marco Solm. Development of an anxiety disorder following an emergency department visit due to cannabis use: a population-based cohort study. EClinicalMedicine. vol 69. 2024-03-28. PMID:38544799. there is ongoing uncertainty about whether cannabis use increases the risk of developing an anxiety disorder. 2024-03-28 2024-03-30 Not clear
Daniel T Myran, Lyndsay D Harrison, Michael Pugliese, Peter Tanuseputro, Adrienne Gaudreault, Jess G Fiedorowicz, Marco Solm. Development of an anxiety disorder following an emergency department visit due to cannabis use: a population-based cohort study. EClinicalMedicine. vol 69. 2024-03-28. PMID:38544799. in this study we estimated the risk of having an incident healthcare visit for an anxiety disorder following an emergency department (ed) visit for cannabis use and explored factors associated with increased risk. 2024-03-28 2024-03-30 Not clear
Sonja Elsaid, Ruoyu Wang, Stefan Kloiber, Rebecca Haines-Saah, Ahmed N Hassan, Bernard Le Fol. Expectancies of the Effects of Cannabis Use in Individuals with Social Anxiety Disorder (SAD). Brain sciences. vol 14. issue 3. 2024-03-28. PMID:38539634. expectancies of the effects of cannabis use in individuals with social anxiety disorder (sad). 2024-03-28 2024-03-30 Not clear
Sonja Elsaid, Ruoyu Wang, Stefan Kloiber, Rebecca Haines-Saah, Ahmed N Hassan, Bernard Le Fol. Expectancies of the Effects of Cannabis Use in Individuals with Social Anxiety Disorder (SAD). Brain sciences. vol 14. issue 3. 2024-03-28. PMID:38539634. previous research has indicated that anticipating positive effects from cannabis use may be linked with increased frequency of cannabis consumption, yet these expectancies remain poorly understood in adults with social anxiety disorder (sad). 2024-03-28 2024-03-30 Not clear
Ankita Das, Christian S Hendershot, M Ishrat Husain, Yuliya Knyahnytska, Sonja Elsaid, Bernard Le Foll, Stefan Kloibe. Perceptions, Experiences, and Patterns of Cannabis Use in Individuals with Mood and Anxiety Disorders in the Context of Cannabis Legalization and Medical Cannabis Program in Canada - A Qualitative Study. Pharmacopsychiatry. 2024-03-11. PMID:38467156. perceptions, experiences, and patterns of cannabis use in individuals with mood and anxiety disorders in the context of cannabis legalization and medical cannabis program in canada - a qualitative study. 2024-03-11 2024-03-14 Not clear
Ankita Das, Christian S Hendershot, M Ishrat Husain, Yuliya Knyahnytska, Sonja Elsaid, Bernard Le Foll, Stefan Kloibe. Perceptions, Experiences, and Patterns of Cannabis Use in Individuals with Mood and Anxiety Disorders in the Context of Cannabis Legalization and Medical Cannabis Program in Canada - A Qualitative Study. Pharmacopsychiatry. 2024-03-11. PMID:38467156. perceptions of cannabis as a potential medical treatment for mood and anxiety disorders have been increasing in the context of legalizations, availability, and medical cannabis programs, though current evidence predominately indicates risks and negative effects of cannabis use (cu) on mental health outcomes. 2024-03-11 2024-03-14 Not clear
Alexander Beletsky, Cherry Liu, Bryson Lochte, Nebiyou Samuel, Igor Gran. Cannabis and Anxiety: A Critical Review. Medical cannabis and cannabinoids. vol 7. issue 1. 2024-02-26. PMID:38406383. habitual cannabis use has been associated with anxiety disorders (ad). 2024-02-26 2024-02-28 Not clear
Adam Li, Simon Erridge, Carl Holvey, Ross Coomber, Daniela Barros, Urmila Bhoskar, Matthieu Crews, Lorna Donnelly, Muhammad Imran, Laura Korb, Gracia Mwimba, Simmi Sachdeva-Mohan, James J Rucker, Mikael H Sodergre. UK Medical Cannabis Registry: a case series analyzing clinical outcomes of medical cannabis therapy for generalized anxiety disorder patients. International clinical psychopharmacology. 2024-02-01. PMID:38299624. uk medical cannabis registry: a case series analyzing clinical outcomes of medical cannabis therapy for generalized anxiety disorder patients. 2024-02-01 2024-02-03 Not clear
André J McDonald, Paul Kurdyak, Jürgen Rehm, Michael Roerecke, Susan J Bond. Youth cannabis use and subsequent health service use for mood and anxiety disorders: A population-based cohort study. Psychiatry research. vol 332. 2024-01-04. PMID:38176165. youth cannabis use and subsequent health service use for mood and anxiety disorders: a population-based cohort study. 2024-01-04 2024-01-07 Not clear
André J McDonald, Paul Kurdyak, Jürgen Rehm, Michael Roerecke, Susan J Bond. Youth cannabis use and subsequent health service use for mood and anxiety disorders: A population-based cohort study. Psychiatry research. vol 332. 2024-01-04. PMID:38176165. epidemiologic research suggests a modest association between youth cannabis use and mood and anxiety disorders (mads). 2024-01-04 2024-01-07 Not clear
Matthan Moy, Anh Truonghuynh, Elvia Villarreal, Derek Nea. Antepartum Psychosis in the Setting of Preeclampsia With Severe Features: A Case Report. Cureus. vol 15. issue 11. 2024-01-01. PMID:38161808. this report presents a unique case of a 34-year-old pregnant woman with a past psychiatric history significant for recurrent major depressive disorder, generalized anxiety disorder, and substance use disorder of alcohol and marijuana, who developed preeclampsia with severe features and acute psychosis during the antepartum period. 2024-01-01 2024-01-05 Not clear